| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/07/1995 | US5387509 Antiparasitic agents |
| 02/07/1995 | US5387414 Comprising peptide immunogen with novel epitopes |
| 02/07/1995 | US5387109 Catalyzing oxidation specific to amadori compounds |
| 02/07/1995 | CA1334290C Plant gum material and use thereof in food products |
| 02/07/1995 | CA1334287C Biologically active peptides tan-866 |
| 02/02/1995 | WO1995003419A1 Method for precipitating natural avermectins |
| 02/02/1995 | WO1995003416A1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
| 02/02/1995 | WO1995003415A2 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 02/02/1995 | WO1995003413A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
| 02/02/1995 | WO1995003409A1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003406A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | WO1995003405A2 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | WO1995003333A2 Tryptase inhibitor |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003322A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | WO1995003069A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | WO1995002967A1 Viscous liquid xylitol compositions and method for preparing same |
| 02/02/1995 | WO1995002964A1 Biological control of postharvest diseases by combining a sugar analog with an antagonistic yeast |
| 02/02/1995 | WO1994029446A3 Intracellular binding proteins and use thereof |
| 02/02/1995 | WO1994029442A3 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 02/02/1995 | WO1994028136A3 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes |
| 02/02/1995 | WO1994026925A3 Processes for producing an enzyme |
| 02/02/1995 | CA2168232A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | CA2167808A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | CA2167677A1 Method for the high level expression, purification and refolding of the outer membrane group b porin proteins from neisseria meningitidis |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166890A1 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | CA2166870A1 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | CA2166616A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | CA2164221A1 Tryptase inhibitor |
| 02/01/1995 | EP0636696A1 Process for producing major histocompatibility antigen class ii protein and material having the same immobilized thereon |
| 02/01/1995 | EP0636695A1 Method for producing L-3,4-dihydroxyphenylalanine |
| 02/01/1995 | EP0636694A2 Human and human-like thymopoietin, method for its production and recombinant DNA sequences encoding it |
| 02/01/1995 | EP0636693A2 Maltose-trehalose converting enzyme, and preparation and uses thereof |
| 02/01/1995 | EP0636182A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
| 02/01/1995 | EP0636180A1 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/01/1995 | EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636139A1 Isolation of steroids containing a 5,7-diene functionality from a sterol mixture |
| 02/01/1995 | EP0636030A1 pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 02/01/1995 | EP0500736B1 Recombinant vaccine for porcine pleuropneumonia |
| 02/01/1995 | CN1098099A Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses |
| 01/31/1995 | US5386331 Load beam and flexure assembly having flexible arms with specific width ratios |
| 01/31/1995 | US5386025 Calcium channel compositions and methods |
| 01/31/1995 | US5386013 A polypeptide glycoprotein having hyaluronic acid binding activity; antiinflammatory, antiarthritic, anticancer agents, infections |
| 01/31/1995 | US5385841 Increase production of extracellular enzyme or heterologous polypeptides |
| 01/31/1995 | US5385837 A culture product polypeptides as an antisoilants for washing detergent |
| 01/31/1995 | US5385832 Cultivating cells in growth medium, separating, extracting with methanol and chloroform, acid-washing |
| 01/31/1995 | US5385829 Method of assaying for acyl-L-carnitines and short-chain acyl-carnitines |
| 01/31/1995 | US5385740 Biologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereof |
| 01/31/1995 | CA1334180C Antibiotics r106 |
| 01/31/1995 | CA1334179C Dextran produced by leuconostoc dextranicum |
| 01/31/1995 | CA1334178C Multiribbon microbial cellulose |
| 01/31/1995 | CA1334177C Production of chimeric antibodies by homologous recombination |
| 01/31/1995 | CA1334176C Monoclonal antibody recognizing gamma atrial natriuretic polypeptide |
| 01/30/1995 | CA2126523A1 Jak kinases and regulation of cytokine signal transduction |
| 01/27/1995 | CA2128653A1 Nucleotide sequences allowing the replication and conservation of a genetic information in animal cells |
| 01/26/1995 | WO1995002751A1 Method for repairing a combustion chamber assembly |
| 01/26/1995 | WO1995002695A1 Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity |
| 01/26/1995 | WO1995002693A1 Bacillus thuringiensis isolates and toxins |
| 01/26/1995 | WO1995002692A1 Modified alpha-lactalbumin |
| 01/26/1995 | WO1995002689A1 An enzyme with acetyl esterase activity |
| 01/26/1995 | WO1995002675A1 A detergent composition comprising two cellulase components |
| 01/26/1995 | WO1995002612A1 Monoclonal antibodies to egg yolk immunoglobulins (igy) |
| 01/26/1995 | WO1995002471A1 Removal of paint, lacquer and other coatings from metal and alloy materials |
| 01/26/1995 | WO1994028125A3 Dna encoding prostaglandin receptor ep1 |
| 01/26/1995 | WO1994024559A3 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases |
| 01/26/1995 | CA2167155A1 Modified alpha-lactalbumin |
| 01/26/1995 | CA2166864A1 Removal of paint, lacquer and other coatings from metal and alloy materials |
| 01/26/1995 | CA2166711A1 Bacillus thuringiensis isolates and toxins |
| 01/26/1995 | CA2166682A1 A detergent composition comprising two cellulase components |
| 01/25/1995 | EP0635575A1 Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen |
| 01/25/1995 | EP0635574A1 Selection marker gene free recombinant strains, a method for obtaining them and the use of these strains |
| 01/25/1995 | EP0635573A2 Process for the preparation of native human glicentin |
| 01/25/1995 | EP0635572A2 Biotin biosynthesis in bacillus subtilis |
| 01/25/1995 | EP0635132A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 01/25/1995 | EP0635064A1 Gustducin materials and methods |
| 01/25/1995 | EP0635061A1 A method of limiting the survival of genetically engineered microorganisms in their environment |
| 01/25/1995 | EP0635059A1 Polysaccharide binding fusion proteins and conjugates |
| 01/25/1995 | EP0635057A1 Methods for producing substantially pure eg iii cellulase using polyethylene glycol |
| 01/25/1995 | EP0635056A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor |
| 01/25/1995 | EP0635054A1 Mammalian melanocyte stimulating hormone receptors and uses |
| 01/25/1995 | EP0635053A1 A novel enzyme and a dna sequence |
| 01/25/1995 | EP0635051A1 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |
| 01/25/1995 | EP0635029A1 Cartilage matrix protein and methods for use |
| 01/25/1995 | EP0634938A1 Immunotoxins directed against cd33 related surface antigens |
| 01/25/1995 | EP0600875A4 Purification of recombinant apolipoprotein e from bacteria. |
| 01/25/1995 | EP0483216B1 Preparation of human adherent lymphokine-activated killer (a-lak) cells |
| 01/24/1995 | USRE34837 Feeds |
| 01/24/1995 | US5384398 High molecular mass N,O-sulphated heparosans, process for their preparation and the pharmaceutical compositions which contain them |
| 01/24/1995 | US5384394 Polypeptides useful for treatment of leukemia or uterus tumors |
| 01/24/1995 | US5384259 Construct and method for expression of tetracycline resistance genes in E. Coli |
| 01/24/1995 | US5384258 Bacillus stearothermophilus and E. coli plasmids |
| 01/24/1995 | US5384257 Glucose isomerases with an altered pH optimum |